GTEx AdiposeTissue 20-29 vs 30-39 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx AdiposeTissue 20-29 vs 30-39 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx AdiposeTissue 20-29 vs 30-39 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx AdiposeTissue 20-29 vs 30-39 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx AdiposeTissue 20-29 vs 30-39 Down.

Results found

Linked to

 

Label

Description

 

Gene

SRC kinase signaling inhibitor 1

Gene

WT1 antisense RNA

Gene

MIR924 host gene

Gene

lncRNA osteogenesis associated

Gene

metallothionein 1J, pseudogene

Gene

up-regulated in colorectal cancer liver metastasis

Gene

ADAMTS9 antisense RNA 1

Gene

ankyrin repeat domain 20 family member A8, pseudogene

Gene

stem cell inhibitory RNA transcript

Gene

cytochrome P450 family 4 subfamily F member 35, pseudogene

  • Gene

    SRC kinase signaling inhibitor 1


  • Gene

    WT1 antisense RNA



  • Gene

    lncRNA osteogenesis associated


  • Gene

    metallothionein 1J, pseudogene


  • Gene

    up-regulated in colorectal cancer liver metastasis


  • Gene

    ADAMTS9 antisense RNA 1


  • Gene

    ankyrin repeat domain 20 family member A8, pseudogene


  • Gene

    stem cell inhibitory RNA transcript


  • Gene

    cytochrome P450 family 4 subfamily F member 35, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.